Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print November 21, 2002, doi: 10.1161/01.RES.0000048196.11060.A0
A more recent version of this article appeared on January 10, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/1/41    most recent
01.RES.0000048196.11060.A0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sperry, J. L.
Right arrow Articles by Rade, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sperry, J. L.
Right arrow Articles by Rade, J. J.
Related Collections
Right arrow Animal models of human disease
Right arrow Arterial thrombosis
Right arrow CV surgery: coronary artery disease

Submitted on October 4, 2002
Revised on November 8, 2002
Accepted on November 11, 2002

Wall Tension Is a Potent Negative Regulator of In Vivo Thrombomodulin Expression

Jason L. Sperry ; Clayton B. Deming ; Ce Bian ; Peter L. Walinsky ; David A. Kass ; Frank D. Kolodgie ; Renu Virmani ; Antony Y. Kim ; and Jeffrey J. Rade *

From the Division of Cardiology (C.B., C.B.D., D.A.K., A.Y.K., J.J.R.), Department of Surgery (J.L.S., P.L.W.) of the Johns Hopkins School of Medicine, Baltimore, Md; and the Armed Forces Institute of Pathology (F.D.K., R.V.), Washington, DC.

* To whom correspondence should be addressed. E-mail: jjrade{at}jhmi.edu.

Thrombomodulin (TM), a key component of the anticoagulant protein C pathway, is a major contributor to vascular thromboresistance. We previously found that TM protein expression is dramatically reduced in autologous vein grafts during the first two weeks after implantation, coincident to a local inflammatory response, and remains suppressed for at least 6 weeks. To determine the proximate cause of TM loss, in vivo gene expression was quantified by real-time PCR. TM gene expression in vein grafts declined >85% during the first postoperative week and remained suppressed >55% at 6 weeks, accounting for the observed changes in protein expression. The effects of vein graft inflammation were evaluated in animals rendered leukopenic with vinblastine before graft implantation. Abrogating the local inflammatory response affected neither TM protein nor gene expression. To determine how hemodynamic forces might modulate TM expression, the surgical protocol was modified to alter blood flow and pressure-induced vessel distension. TM protein and gene expression did not correlate to changes in shear stress but highly correlated to changes in wall tension, both acutely and over time. We conclude that the primary stimulus for altered TM expression in vein grafts is the exposure to arterial pressure. Furthermore, these data identify strain as a novel and important pathway for in vivo TM gene regulation.


Key words: thrombomodulin • wall tension • shear stress • thrombosis • vein graft




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. Aitsebaomo, A. L. Portbury, J. C. Schisler, and C. Patterson
Brothers and Sisters: Molecular Insights Into Arterial-Venous Heterogeneity
Circ. Res., October 24, 2008; 103(9): 929 - 939.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Joner, G. Nakazawa, A. V. Finn, S. C. Quee, L. Coleman, E. Acampado, P. S. Wilson, K. Skorija, Q. Cheng, X. Xu, et al.
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 333 - 342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Jiang, P. Yu, M. Tao, C. Fernandez, C. Ifantides, O. Moloye, G. S. Schultz, C. K. Ozaki, and S. A. Berceli
TGF-beta- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H482 - H488.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. C. Aird
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circ. Res., February 2, 2007; 100(2): 174 - 190.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. K. Kapur, C. B. Deming, S. Kapur, C. Bian, H. C. Champion, J. K. Donahue, D. A. Kass, and J. J. Rade
Hemodynamic Modulation of Endocardial Thromboresistance
Circulation, January 2, 2007; 115(1): 67 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Tabuchi, M. Shichiri, A. Shibamiya, T. Koyama, F. Nakazawa, J. Chung, S. Hirosawa, and M. Sunamori
Non-viral in vivo thrombomodulin gene transfer prevents early loss of thromboresistance of grafted veins
Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 995 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. V. de Wouwer, D. Collen, and E. M. Conway
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1374 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. C. Cooley
Murine Model of Neointimal Formation and Stenosis in Vein Grafts
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1180 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. R. Lentz
Thrombosis of Vein Grafts: Wall Tension Restrains Thrombomodulin Expression
Circ. Res., January 10, 2003; 92(1): 12 - 13.
[Full Text] [PDF]